CN3743075
Active
Amendment A1
National Supply arrangement for imported immunoglobulin products
National Blood Authority has a limited-tender contract with Grifols Australia Pty Ltd worth AU$891,884,206 for a national supply arrangement of imported immunoglobulin products from December 2020 to December 2027. The procurement was exempt under TR 10.3.d.iii due to an absence of competition for technical reasons, and the contract has one amendment.
$891.9M
Contract Value
Contract Details
- Contract ID
- CN3743075
- Status
- active
- Financial Year
- FY26
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Key Dates
- Publish Date
- 9 June 2026
- Signed Date
- 19 Jan 2021
- Start Date
- 31 Dec 2020
- End Date
- 30 Dec 2027
- Duration
- 7 years, 1 month
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- TR
- Exemption Reason
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
Contract History
This contract has been amended 1 time. Currently showing amendment A1.
Original Contract
Published 19 Jan 2021 · 31 Dec 2020 to 30 Dec 2027
$607.7M
Amendment A1
Current
Published 9 June 2026 · 31 Dec 2020 to 30 Dec 2027
$891.9M
+$284.2M
Supplier
GRIFOLS AUSTRALIA PTY LTD
- ABN
- 35 050 104 875
- Entity Type
- Australian Private Company
- Location
- VIC